Human DNA methylomes of neurodegenerative diseases show common epigenomic patterns
暂无分享,去创建一个
J R Ecker | M. Esteller | J. Dopazo | J. Ecker | H. Heyn | M. Schultz | M. Dierssen | S. Moran | S. Sayols | J. Ávila | J. Sanchez-Mut | I. Lott | A. Rábano | I. Ferrer | M. M. de Lagrán | E. Vidal | M Esteller | P. Garcia-Esparcia | B. Ansoleaga | J Avila | J Dopazo | E Vidal | S Sayols | S Moran | H Heyn | M Dierssen | I Ferrer | I Lott | J V Sanchez-Mut | R Delgado-Morales | M D Schultz | B Ansoleaga | P Garcia-Esparcia | M Pons-Espinal | M M de Lagran | A Rabano | M. Pons-Espinal | R. Delgado-Morales
[1] Matthew Baker,et al. Amyloid-β alters the DNA methylation status of cell-fate genes in an Alzheimer's disease model. , 2013, Journal of Alzheimer's disease : JAD.
[2] K. Gunderson,et al. High density DNA methylation array with single CpG site resolution. , 2011, Genomics.
[3] Tomaž Curk,et al. Analysis of alternative splicing associated with aging and neurodegeneration in the human brain. , 2011, Genome research.
[4] J. Valero,et al. The role of CREB signaling in Alzheimer’s disease and other cognitive disorders , 2011, Reviews in the neurosciences.
[5] M. Esteller,et al. Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome , 2011, Epigenetics.
[6] Manolis Kellis,et al. Alzheimer's disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci , 2014 .
[7] Steven J. M. Jones,et al. Circos: an information aesthetic for comparative genomics. , 2009, Genome research.
[8] J. Sweatt,et al. The Emerging Field of Neuroepigenetics , 2013, Neuron.
[9] M. Hemberg,et al. Tau promotes neurodegeneration through global chromatin relaxation , 2014, Nature Neuroscience.
[10] Matthew D. Schultz,et al. Global Epigenomic Reconfiguration During Mammalian Brain Development , 2013, Science.
[11] Alfonso Valencia,et al. Distinct DNA methylomes of newborns and centenarians , 2012, Proceedings of the National Academy of Sciences.
[12] A. Saykin,et al. Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer's disease, Parkinson's disease, and related disorders. , 2013, American journal of neurodegenerative disease.
[13] Lee E. Edsall,et al. Human DNA methylomes at base resolution show widespread epigenomic differences , 2009, Nature.
[14] J. Trojanowski,et al. Antibodies to α‐synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease , 1999, Annals of neurology.
[15] A. Lang,et al. Interface between tauopathies and synucleinopathies: A tale of two proteins , 2006, Annals of neurology.
[16] Martin Dugas,et al. Detection of significantly differentially methylated regions in targeted bisulfite sequencing data , 2013, Bioinform..
[17] Feng Lin,et al. A signal-noise model for significance analysis of ChIP-seq with negative control , 2010, Bioinform..
[18] B. Langmead,et al. BSmooth: from whole genome bisulfite sequencing reads to differentially methylated regions , 2012, Genome Biology.
[19] Manel Esteller,et al. Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies , 2009, The Lancet Neurology.
[20] R. Chatterjee,et al. CG methylation. , 2012, Epigenomics.
[21] D. Bennett,et al. Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer's disease , 2014, Nature Neuroscience.
[22] H. Cedar,et al. Linking DNA methylation and histone modification: patterns and paradigms , 2009, Nature Reviews Genetics.
[23] P. L. Peng,et al. Deregulation of HDAC1 by p25/Cdk5 in Neurotoxicity , 2008, Neuron.
[24] Alexander Meissner,et al. Association of Brain DNA methylation in SORL1, ABCA7, HLA-DRB5, SLC24A4, and BIN1 with pathological diagnosis of Alzheimer disease. , 2015, JAMA neurology.
[25] T. Hensch,et al. DNA methylation map of mouse and human brain identifies target genes in Alzheimer’s disease , 2013, Brain : a journal of neurology.
[26] Chris Sander,et al. A Role for Neuronal piRNAs in the Epigenetic Control of Memory-Related Synaptic Plasticity , 2012, Cell.
[27] Hedi Peterson,et al. g:Profiler—a web-based toolset for functional profiling of gene lists from large-scale experiments , 2007, Nucleic Acids Res..
[28] Howard Hu,et al. Genome-wide DNA methylation differences between late-onset Alzheimer's disease and cognitively normal controls in human frontal cortex. , 2012, Journal of Alzheimer's disease : JAD.
[29] Bin Zhang,et al. Distinct α-Synuclein Strains Differentially Promote Tau Inclusions in Neurons , 2013, Cell.
[30] S. Rapoport,et al. Epigenetic modifications in frontal cortex from Alzheimer's disease and bipolar disorder patients , 2012, Translational Psychiatry.
[31] J. Grafman,et al. Human prefrontal cortex: processing and representational perspectives , 2003, Nature Reviews Neuroscience.
[32] G. Strobel. The spectrum series: grappling with the overlap between Alzheimer's and Parkinson's diseases. 9th International Conference on Alzheimer's and Parkinson's Diseases, 11-15 March 2009, Prague,Czech Republic. , 2009, Journal of Alzheimer's disease : JAD.
[33] M. Esteller,et al. Promoter Hypermethylation of the Phosphatase DUSP22 Mediates PKA-Dependent TAU Phosphorylation and CREB Activation in Alzheimer's Disease , 2014, Hippocampus.
[34] U. Wüllner,et al. Genome-scale methylation analysis of Parkinson's disease patients' brains reveals DNA hypomethylation and increased mRNA expression of cytochrome P450 2E1 , 2012, neurogenetics.
[35] James A. Eddy,et al. Cell type-specific genes show striking and distinct patterns of spatial expression in the mouse brain , 2013, Proceedings of the National Academy of Sciences.
[36] Lydia Ng,et al. Clustering of spatial gene expression patterns in the mouse brain and comparison with classical neuroanatomy. , 2010, Methods.
[37] Luca Muzio,et al. Emx1, emx2 and pax6 in specification, regionalization and arealization of the cerebral cortex. , 2003, Cerebral cortex.
[38] I. McKeith,et al. Spectrum of Parkinson's disease, Parkinson's dementia, and Lewy body dementia. , 2000, Neurologic clinics.